Pediatrix Medical Group, Inc.
MD- Exchange
- NYSE
- Industry
- Services-Hospitals
- SEC CIK
- 0000893949
No open-market purchases or sales by Pediatrix Medical Group, Inc. insiders were filed in the last 90 days; 304 institutions reported holding it in 13F filings for Q2 2026, worth $2.12B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pediatrix Medical Group, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pediatrix Medical Group, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Linynsky Laura A | Director | 33,900 | Sep 14, 2026 | 4 |
| Young Sylvia Jean | Director | 29,786 | Aug 18, 2026 | 3 |
| McEachin Thomas | Director | 7,668 | Aug 14, 2026 | 3 |
| Weis Shirley A | Director | 19,095 | Aug 14, 2026 | 3 |
| Starcher John M. Jr. | Director | 73,732 | Aug 14, 2026 | 2 |
| Newman Kurt Douglas | Director | 17,405 | Aug 14, 2026 | 2 |
| Rucker Michael A. | Director | 66,769 | Aug 14, 2026 | 3 |
| Sansone Guy P | Director | 87,416 | Aug 14, 2026 | 2 |
| Haddock David | EVP, GC & Corp Sec | 20,036 | Jun 24, 2026 | 1 |
| Moore Mary Ann E | EVP, GC, Chief Admin Off & Sec | 111,831Indirect | Jun 10, 2026 | 4 |
| Ordan Mark S | Chief Executive Officer | 410,884 | Jun 3, 2026 | 2 |
| Rossi Kasandra H | EVP, CFO and Treasurer | 101,399 | Jun 3, 2026 | 2 |
| Neeb Don Gregory | EVP, Chief Invest & Strategy | 137,231 | Jun 3, 2026 | 1 |
| Swift James D | Chief Executive Officer | 170,001 | Sep 3, 2024 | 0 |
| Richards C Marc | EVP, Chief Financial Officer | 175,347 | Aug 13, 2024 | 0 |
| Pickert Curtis | EVP, Chief Operating Officer | 118,318 | Jun 4, 2024 | 0 |
| Wood Lee | EVP, Natl & Market Operations | 117,281 | Jun 4, 2024 | 0 |
| Andreano Dominic J | EVP, General Counsel and Secy | 189,440 | Sep 28, 2022 | 0 |
| Medel Roger MD | Director | 747,930 | May 13, 2022 | 0 |
| Hinson Roger Mack | Pres., PDX & OBX Medical Group | 109,457 | Mar 3, 2022 | 0 |
| Pepia John C | Principal Accounting Officer | 96,666 | Nov 10, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 (view filing) | May 13 | 1 day | Weis Shirley ADirector | SSale | −36.0K | $23.75 | −$855.7K | −100.0%0 after | |
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Ordan Mark SChief Executive Officer | SSale | −23.0K | $22.41 | −$515.4K | −7.1%302.8K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Rucker Michael A.Director | SSale | −10.5K | $23.00 | −$241.0K | −15.1%59.1K after | |
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Linynsky Laura ADirector | SSale | −10.0K | $21.65 | −$216.5K | −23.7%32.2K after | |
| Nov 14, 2024 (view filing) | Nov 13 | 1 day | Ordan Mark SDirector | SSale | −27.6K | $15.35 | −$423.7K | −16.6%138.7K after | |
| Nov 12, 2024 (view filing) | Nov 8 | 4 days | Moore Mary Ann EEVP, GC, Chief Admin Off & Sec | SSale | −8.11K | $16.00 | −$129.7K | −5.6%135.8K after | |
| Sep 3, 2024 (view filing) | Aug 30 | 4 days | Swift James DChief Executive Officer | SSale | −11.1K | $10.79 | −$119.8K | −6.1%170.0K after | |
| Aug 29, 2024 (view filing) | Aug 27 | 2 days | Linynsky Laura ADirector | SSale | −7.00K | $11.16 | −$78.1K | −18.5%30.8K after | |
| Aug 13, 2024 (view filing) | Aug 9-12 | 4 days | Richards C MarcEVP, Chief Financial Officer | SSale | −50.0K | $10.08 | −$504.0K | −22.2%175.3K after | 2 lots |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Moore Mary Ann EEVP, General Counsel & Sec | SSale | −1.15K | $9.62 | −$11.1K | −6.8%15.7K after | |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Moore Mary Ann EEVP, General Counsel & Sec | SSale | −970 | $9.62 | −$9.33K | −1.2%81.4K after | |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Swift James DChief Executive Officer | SSale | −5.76K | $9.58 | −$55.2K | −6.0%90.9K after | |
| Jun 16, 2023 (view filing) | Jun 14 | 2 days | Swift James DChief Executive Officer | SSale | −13.2K | $14.14 | −$186.5K | −12.0%96.6K after | |
| May 26, 2023 (view filing) | May 25 | 1 day | Ordan Mark SDirector | SSale | −33.0K | $13.26 | −$437.6K | −18.2%147.9K after | |
| May 22, 2023 (view filing) | May 18-19 | 4 days | Weis Shirley ADirector | SSale | −19.0K | $13.55 | −$257.5K | −51.8%17.7K after | 2 lots |
| Nov 23, 2022 (view filing) | Nov 21 | 2 days | Ordan Mark SChief Executive Officer | SSale | −22.2K | $15.45 | −$342.5K | −6.0%346.6K after | |
| Nov 9, 2022 (view filing) | Nov 7 | 2 days | Swift James DEVP, Chief Operating Officer | SSale | −24.0K | $15.31 | −$367.4K | −21.4%88.0K after | |
| Jan 11, 2022 (view filing) | Jan 10-11 | 1 day | Medel Roger MDDirector | SSale | −100.0K | $26.50 | −$2.65M | −11.9%739.5K after | 2 lots |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Medel Roger MDDirector | SSale | −12.6K | $27.42 | −$346.6K | −1.5%839.5K after | |
| Jan 4, 2022 (view filing) | Dec 31, 2021-Jan 4, 2022 | 4 days | Medel Roger MDDirector | SSale | −93.9K | $27.41 | −$2.57M | −9.9%852.1K after | 2 lots |
| Dec 30, 2021 (view filing) | Dec 30 | Same day | Medel Roger MDDirector | SSale | −45.4K | $27.19 | −$1.23M | −4.6%946.0K after | |
| Dec 29, 2021 (view filing) | Dec 27-29 | 2 days | Medel Roger MDDirector | SSale | −136.4K | $27.23 | −$3.71M | −12.1%991.4K after | 3 lots |
| Nov 10, 2021 (view filing) | Nov 10 | Same day | Hinson Roger MackPres., PDX & OBX Medical Group | SSale | −8.80K | $28.38 | −$249.7K | −7.6%107.4K after | |
| Nov 10, 2021 (view filing) | Nov 10 | Same day | Pepia John CPrincipal Accounting Officer | SSale | −5.00K | $28.45 | −$142.3K | −4.9%96.7K after | |
| Oct 29, 2021 (view filing) | Oct 29 | Same day | Pepia John CPrincipal Accounting Officer | SSale | −9.24K | $26.87 | −$248.2K | −8.3%101.7K after | |
| Oct 29, 2021 (view filing) | Oct 28 | 1 day | Medel Roger MDDirector | SSale | −10.4K | $29.00 | −$301.2K | −0.9%1.13M after | |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Medel Roger MDDirector | SSale | −1.27K | $29.00 | −$36.8K | −0.1%1.14M after | |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Pepia John CPrincipal Accounting Officer | SSale | −10.0K | $31.83 | −$318.3K | −8.3%110.8K after | |
| Aug 31, 2021 (view filing) | Aug 30 | 1 day | Ordan Mark SChief Executive Officer | SSale | −95.0K | $35.09 | −$3.33M | −31.3%208.4K after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Hinson Roger MackPres., PDX & OBX Medical Group | SSale | −8.80K | $32.35 | −$284.6K | −7.0%116.1K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Medel Roger MDDirector | SSale | −100.0K | $30.31 | −$3.03M | −7.6%1.22M after |